Embecta to host Analyst and Investor Day on May 22, 2025
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced its upcoming Analyst and Investor Day scheduled for May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.
The event will feature presentations from President & CEO Dev Kurdikar, CFO Jake Elguicze, and other leadership team members. They will discuss:
- Strategic and business overview
- Value creation opportunities
- Company's financial profile
- Long-term objectives
While in-person attendance is by invitation only, interested parties can participate via webcast through InvestorDay.embecta.com. A replay and presentation materials will be available in the 'Events & Presentations' section of the company's Investor Relations website after the event.
Embecta (Nasdaq: EMBC), azienda globale specializzata nella cura del diabete e nella somministrazione di insulina, ha annunciato il suo prossimo Analyst and Investor Day, previsto per il 22 maggio 2025, dalle 9:00 alle 12:30 a New York City.
L'evento includerà interventi del Presidente e CEO Dev Kurdikar, del CFO Jake Elguicze e di altri membri del team dirigenziale. Verranno trattati i seguenti temi:
- Panoramica strategica e commerciale
- Opportunità di creazione di valore
- Profilo finanziario dell'azienda
- Obiettivi a lungo termine
La partecipazione in presenza è riservata esclusivamente su invito, ma gli interessati potranno seguire l'evento in diretta streaming su InvestorDay.embecta.com. La registrazione e i materiali della presentazione saranno disponibili nella sezione 'Events & Presentations' del sito Investor Relations dell’azienda dopo l'evento.
Embecta (Nasdaq: EMBC), una compañía global dedicada al cuidado de la diabetes y especializada en la administración de insulina, ha anunciado su próximo Analyst and Investor Day, programado para el 22 de mayo de 2025, de 9:00 a.m. a 12:30 p.m. en la ciudad de Nueva York.
El evento contará con presentaciones del presidente y CEO Dev Kurdikar, el CFO Jake Elguicze y otros miembros del equipo directivo. Se abordarán los siguientes temas:
- Visión estratégica y comercial
- Oportunidades para crear valor
- Perfil financiero de la empresa
- Objetivos a largo plazo
La asistencia presencial es solo con invitación, pero los interesados pueden participar vía webcast en InvestorDay.embecta.com. La repetición y los materiales de la presentación estarán disponibles en la sección 'Events & Presentations' del sitio web de Relaciones con Inversores de la empresa después del evento.
Embecta (나스닥: EMBC)는 인슐린 전달을 전문으로 하는 글로벌 당뇨병 관리 회사로, 2025년 5월 22일 오전 9시부터 12시 30분까지 뉴욕시에서 열리는 애널리스트 및 투자자 데이를 발표했습니다.
이번 행사에서는 사장 겸 CEO Dev Kurdikar, CFO Jake Elguicze 및 기타 경영진이 발표를 진행하며 다음 주제를 다룰 예정입니다:
- 전략 및 비즈니스 개요
- 가치 창출 기회
- 회사의 재무 프로필
- 장기 목표
현장 참석은 초청받은 분들만 가능하며, 관심 있는 분들은 InvestorDay.embecta.com을 통해 웹캐스트로 참여할 수 있습니다. 행사 후 회사 투자자 관계 웹사이트의 'Events & Presentations' 섹션에서 다시보기와 발표 자료를 제공할 예정입니다.
Embecta (Nasdaq : EMBC), une entreprise mondiale spécialisée dans les soins du diabète et la distribution d'insuline, a annoncé sa prochaine Journée Analystes et Investisseurs prévue le 22 mai 2025, de 9h00 à 12h30 à New York.
L'événement comprendra des présentations du Président-directeur général Dev Kurdikar, du directeur financier Jake Elguicze, ainsi que d'autres membres de l'équipe dirigeante. Ils aborderont :
- Un aperçu stratégique et commercial
- Les opportunités de création de valeur
- Le profil financier de l'entreprise
- Les objectifs à long terme
La participation en présentiel est réservée aux personnes invitées, mais les intéressés peuvent suivre l'événement en webcast via InvestorDay.embecta.com. Un replay ainsi que les documents de présentation seront disponibles dans la section « Events & Presentations » du site Relations Investisseurs de l’entreprise après l'événement.
Embecta (Nasdaq: EMBC), ein weltweit tätiges Unternehmen im Bereich Diabetesversorgung mit Schwerpunkt auf Insulinabgabe, hat seinen bevorstehenden Analyst and Investor Day angekündigt, der am 22. Mai 2025 von 9:00 bis 12:30 Uhr in New York City stattfinden wird.
Die Veranstaltung umfasst Präsentationen von Präsident und CEO Dev Kurdikar, CFO Jake Elguicze sowie weiteren Mitgliedern des Führungsteams. Es werden folgende Themen behandelt:
- Strategische und geschäftliche Übersicht
- Chancen zur Wertschöpfung
- Finanzprofil des Unternehmens
- Langfristige Ziele
Die persönliche Teilnahme ist nur auf Einladung möglich, Interessierte können jedoch über einen Webcast auf InvestorDay.embecta.com teilnehmen. Eine Aufzeichnung und Präsentationsmaterialien stehen nach der Veranstaltung im Bereich 'Events & Presentations' der Investor-Relations-Website des Unternehmens zur Verfügung.
- None.
- None.
PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.
Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.
To register for the webcast, please go to: embecta Analyst & Investor Day Webcast Registration.
Visit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the "Events & Presentations" section of the Company's Investor Relations website following the conclusion of the event.
In-person attendance is by invitation only.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When is Embecta's (EMBC) Analyst and Investor Day 2025?
How can investors attend Embecta's (EMBC) Investor Day 2025?
What topics will be covered at Embecta's (EMBC) 2025 Investor Day?
Who will be presenting at Embecta's (EMBC) 2025 Investor Day?
Where can I find materials from Embecta's (EMBC) 2025 Investor Day?
